Results 311 to 320 of about 66,190,054 (394)

MED-EL hearing solution registry: An examination of the strengths and limitations of a cochlear implant registry. [PDF]

PLoS One
Baumann U, Weissgerber T, Radeloff A, Koinig KA, Breu M, Rinnofner J, Lohnherr V, Dazert S, Völter C, Anderson I, Müller J, Polterauer D.   +11 more
europepmc   +1 more source

A Method of Evaluating Solubility Parameter from Gas Chromatographic Data.

, 1959
Nobuo Takamiya, Junichi Kojima, Sukenaga Murai   +2 more
openalex   +2 more sources

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Establishment of a Diabetes-Tailored Data Intelligence Platform Enhances Clinical Care, Enables Risk-Based Monitoring, and Facilitates Population-Health-Based Approaches at a Pediatric Diabetes Network. [PDF]

J Diabetes Sci Technol
Lockee B, Vandervelden CA, Tilden DR, Panfil K, Tallon EM, DeWit E, Noland K, Williams DD, Gill H, Patton SR, Prahalad P, Espinoza J, Waghmode A, Barnes M, Clements MA.   +14 more
europepmc   +1 more source

Methods for computing and intercomparing radiation data

, 1919
W. W. Coblentz
openalex   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

Best Practices for Data Modernization Across the United States Public Health System: Scoping Review.

J Med Internet Res
Zeba Z, Lartey ST, Durneva P, Roy S, Jha N, Ofori MA, Mittal N, Dockery S, Scarboro NS, Taylor M, Joshi A.   +10 more
europepmc   +1 more source

Big data in modelling geographical accessibility to healthcare: a scoping review protocol. [PDF]

BMJ Open
Njogu A, Libertini L, Avahoundjè EM, Grovogui FM, Ba OA, Ray N, Beňová L, Macharia PM.   +7 more
europepmc   +1 more source

Handbook of the flora of Philadelphia and vicinity, containing data relating to the plants within the following radius: eastern Pennsylvania; all of New Jersey except the northern counties; and New Castle County, Delaware, with keys for identification of species

, 1905
Ida A. Keller, Stewardson Brown
openalex   +2 more sources

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source